Brief: Glaxosmithkline Pharma Sept-Quarter Consol Profit Rises
29/10/2021 12:14
Oct 29 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd
GLAX.NS :
* GLAXOSMITHKLINE PHARMA SEPT-QUARTER CONSOL PROFIT 2.04
BILLION
RUPEES VERSUS 764.7 MILLION RUPEES YEAR AGO
* GLAXOSMITHKLINE PHARMA SEPT-QUARTER CONSOL REVENUE FROM
OPERATIONS 10.10 BILLION RUPEES VERSUS 8.79 BILLION RUPEES YEAR
AGO
Source text for Eikon: ID:nBSE4hks5l
Further company coverage: GLAX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees